Skip to Main Content

Paper Details

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.
Proc Natl Acad Sci U S A
10
2023
Author NameAffiliation
Ravindra MajetiStanford University
Ravindra MajetiInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University
Carolyn R BertozziStanford University
Carolyn R BertozziStanford University
Carolyn R BertozziHoward Hughes Medical Institute, Stanford University
  • 1 - 5

Datasets

Release 1.2